Reuters logo
BRIEF-Rodin Therapeutics advances synaptic resilience strategy
September 18, 2017 / 11:18 AM / 3 months ago

BRIEF-Rodin Therapeutics advances synaptic resilience strategy

Sept 18 (Reuters) -

* Rodin Therapeutics - announced completion of $27 million financing round that included Atlas Venture, Remeditex Ventures, Third Point Ventures Source text for Eikon:

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below